MindMed To Include MDMA to Research Portfolio

Neuro-pharmaceutical and psychedelics research company Mind Medicine Inc. MMED MMEDF announced Wednesday the inclusion of the psychoactive compound MDMA to its R&D pipeline.

The move comes as part of the company’s exclusive collaboration agreement with the University Hospital Basel’s Liechti Lab

A Potential in Combining MDMA with Other Psychedelics

“We see an amazing opportunity to optimize the subjective effect profiles of known psychedelics like LSD and MDMA to potentially make a more advanced and comfortable therapeutic experience for the patient,” JR Rahn, CEO of MindMed, told Benzinga.

University of Basel Professor Dr. Matthias Liechti, who was one of the original scientific researchers to discover the mechanism of action of MDMA in the 1990s, said that his lab has generated a large amount of data on the pharmacokinetics, pharmacogenetics and safety of MDMA in over 10 years of clinical research.

MindMed will leverage Liechti’s experience in leading multiple clinical trials of the safety profile of MDMA to explore ways to develop psychedelic therapies combining MDMA and LSD.

“We are most interested in how MDMA can be combined with other medicines or psychedelics and plan to focus our R+D funding on developing this concept further for patients,” said Rahn.

MDMA was granted “Breakthrough Therapy” designation by the FDA in 2017, revealing the agency’s consideration that MDMA-assisted psychotherapy may have a meaningful advantage over available medications for PTSD.

Posted In: Dr. Matthias LiechtiJR RahnLSDMDMAMindMedpsychedelicsCannabisHealth CareMarketsGeneral

Ad Disclosure: The rate information is obtained by Bankrate from the listed institutions. Bankrate cannot guaranty the accuracy or availability of any rates shown above. Institutions may have different rates on their own websites than those posted on Bankrate.com. The listings that appear on this page are from companies from which this website receives compensation, which may impact how, where, and in what order products appear. This table does not include all companies or all available products.

All rates are subject to change without notice and may vary depending on location. These quotes are from banks, thrifts, and credit unions, some of whom have paid for a link to their own Web site where you can find additional information. Those with a paid link are our Advertisers. Those without a paid link are listings we obtain to improve the consumer shopping experience and are not Advertisers. To receive the Bankrate.com rate from an Advertiser, please identify yourself as a Bankrate customer. Bank and thrift deposits are insured by the Federal Deposit Insurance Corp. Credit union deposits are insured by the National Credit Union Administration.

Consumer Satisfaction: Bankrate attempts to verify the accuracy and availability of its Advertisers' terms through its quality assurance process and requires Advertisers to agree to our Terms and Conditions and to adhere to our Quality Control Program. If you believe that you have received an inaccurate quote or are otherwise not satisfied with the services provided to you by the institution you choose, please click here.

Rate collection and criteria: Click here for more information on rate collection and criteria.